Clinical trial
A Clinical Study of Immune Globulin Intravenous (Human) Omr-IgG-am IGIV in Subjects With Primary Immune Deficiency Diseases
NCT00468273 is registered in ClinicalTrials.gov with FFF Enterprises as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Study of Immune Globulin Intravenous (Human) Omr-IgG-am IGIV in Subjects With Primary Immune Deficiency Diseases
- Lead sponsor
- FFF Enterprises
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 30, 2006
- Completion date
- August 31, 2009
- Enrollment
- 57 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.